⌘K
S
Secretome Therapeutics
Regenerative medicine • Clinical studies
Secretome Therapeutics develops regenerative medicine solutions and is advancing its lead asset, STM-01, into Phase I clinical studies.
Regenerative medicine • Clinical studies
Secretome Therapeutics develops regenerative medicine solutions and is advancing its lead asset, STM-01, into Phase I clinical studies.